InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: jaybe post# 81967

Friday, 09/21/2018 12:36:55 PM

Friday, September 21, 2018 12:36:55 PM

Post# of 108192
"Setting an eligibility criteria for AXAL treatment of AA T <3.5 may increase 12 month survival from 38% to 49% and median survival from 6.2 months to 10.3 months in advanced cervical cancer".

Now, imagine using that criteria combined with a CI and/or HOT or NEO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News